This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
BackgroundNon-valvular atrial fibrillation (NVAF) significantly increases ischemic stroke and systemic embolism (SE) risks. OAC users predominantly had cardiovasculardisease and risk factors, whereas non-OAC users had higher rates of malignancy and dementia. for stroke/SE-specific, p-value<0.001).
Three common cardiovasculardiseases in adults—heart failure, atrial fibrillation and coronary heart disease—are linked to cognitive impairment and increased risk of dementia, according to "Cardiac Contributions to Brain Health," a new scientific statement from the American Heart Association published today in the journal, Stroke.
Reduction in low-density lipoprotein cholesterol (LDL-C) levels has consistently demonstrated a reduced risk of atherosclerotic cardiovasculardisease (ASCVD). There is extensive evidence from randomized trials that demonstrates the effectiveness of lipid-lowering agents in reducing ASCVD-related events.
A study found that the protein ADM significantly mediates loneliness' link to cardiovasculardisease, stroke, dementia, and mortality, emphasizing loneliness health risks.
I am going to start with the answer to the question of whether statins cause dementia and then provide the details backing up my answer. Statins do not cause dementia. But if you are someone who thinks that statins do cause dementia and you need to see the evidence to refute that claim, then read on. The answer is: No.
Stroke, Ahead of Print. The burden of neurologic diseases, including stroke and dementia, is expected to grow substantially in the coming decades. Cardiovasculardiseases are the leading cause of death and disability in the United States and around the world.
Poor Sleep Might Eliminate The Benefits Of Exercise & Dementia. High levels of aerobic fitness are closely linked to lower rates of future dementia 1. Regular physical activity is arguably one of the biggest factors preventing dementia. When it comes to preventing dementia, this could not be truer.
That is severe obstructive sleep apnea (OSA), and with that serious interruption to sleep quality also comes a doubling in the risk of future heart disease, particularly stroke 6. For example, people with type 2 diabetes are 10 times more likely to develop cardiovasculardisease than those who do not have diabetes 10.
They get the diseases of ageing about 20 to 25 years later than everyone else. It’s not that they don’t get cardiovasculardisease, cancer or dementia; they just get it way later than everyone else. Most adults, healthy centenarians included, will die from one of three things: CardiovascularDisease.
Cardiovasculardisease, cancer and dementia account for 60% of all deaths in the US. For those in the ‘Ideal’ category, they were 51% less likely to have either dementia or depression. In most developed countries as of today, NCDs account for 89% of all deaths. The leading causes of death are clear.
While I have covered many of these fitness measures individually in previous posts, I wanted to summarise these metrics and how they relate to living longer and preventing major diseases such as cardiovasculardisease, cancer and dementia. JAMA Netw Open. 2018;1(6):e183605. BMC Endocr Disord 22 , 297 (2022).
Objectives Elevated low-density lipoprotein cholesterol (LDL-C) increases the risk of recurrent cardiovasculardisease (CVD) events. We examined use of lipid-lowering therapy (LLT) following ischaemic stroke, and estimated benefits from guideline-based up-titration of LLT. and women (coefficient –5.1 to –0.9)
Introduction: Addressing the Need for Improved LDL Management in the US There is a clear need for innovative treatments to combat cardiovasculardisease (CVD). Heart disease remains the leading cause of death for men and women. However, every 40 seconds, an individual in the US suffers a heart attack.
Stroke, Volume 56, Issue Suppl_1 , Page AWMP13-AWMP13, February 1, 2025. Cognitive impairment (CGI) is common in patients with cardiovasculardiseases, contributing to morbidity and mortality, especially among people over the age of 64.
Stroke, Volume 56, Issue Suppl_1 , Page ADP22-ADP22, February 1, 2025. Introduction:Covert brain infarcts (CBIs) are associated with risk of stroke and dementia. Methods:Inclusion criteria were age > 40 years, no prior stroke or TIA, and available MRI brain scan.
Stroke, Volume 55, Issue Suppl_1 , Page A10-A10, February 1, 2024. Background:Adherence to the American Heart Association's Life’s Essential 8 (LE8) reduces the risk of cardiovasculardisease. Participants with prior stroke, transient ischemic attack (TIA) or myocardial infarction (MI) were excluded.
Stroke, Volume 56, Issue Suppl_1 , Page ADP15-ADP15, February 1, 2025. Background:White matter hyperintensities (WMH) of presumed vascular origin can be associated with vascular cognitive impairment and dementia. However, WMH are also seen in asymptomatic subjects. FLAIR/T1 images were segmented to create WMH masks.
Stroke: Vascular and Interventional Neurology, Volume 3, Issue S2 , November 1, 2023. IntroductionPatients with cognitive impairment often have a history of cardiovasculardisease (CVD) or multiple cardiovascular risk factors (CRFs) such as hypertension, obesity, and hypercholesterolemia.
Insulin resistance is a core risk factor for the three leading causes of death: CardiovascularDisease Cancer Dementia. Subscribe now Take cardiovasculardisease, for example. Insulin resistance is unlikely to be the primary causal factor for these conditions but is likely to be a major accelerant.
Published on November 30, 2023, in the Journal of the American College of Cardiology, these new guidelines are based on a comprehensive literature review from May 2022 to November 2022, and provide important recommendations to clinicians caring for patients with or at risk of developing cardiovasculardisease (CVD). million.
BACKGROUND:Many studies have explored whether individual plasma protein biomarkers improve cardiovasculardisease risk prediction. We sought to investigate the use of a plasma proteomics-based approach in predicting different cardiovascular outcomes.METHODS:Among 51 859 UK Biobank participants (mean age, 56.7
Stroke, Volume 56, Issue 1 , Page 95-104, January 1, 2025. Participants underwent brain magnetic resonance imaging scans every 3 to 4 years between 2005 and 2016. women), large decreases and increases in CBF and increases in CVRi over time were associated with white matter hyperintensity progression.
History of Cardiovasculardisease (all studies): Especially any history of heart failure or structural cardiac disease, including valvular 4. Negative predictors included dementia, pacemaker, coronary revascularization, and cerebrovascular disease. to 1.45) for fatal or nonfatal stroke. to 3.80).
This misinformation would have resulted in many thousands of people giving up their medication and suffering heart attacks and strokes as a result. The hypothesis that a raised cholesterol level causes heart disease [atherosclerotic cardiovasculardisease (ASCVD)] is possibly the single most powerful idea in medicine.
Stroke, Ahead of Print. BACKGROUND:Modifiable risk factors play a central role in the development and course of neurodegenerative disorders of later life, including dementias.
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content